F. Hoffmann-La Roche Ltd: FDA approves Roche's Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
Kauppalehti2h
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...
DIA 2025 Global Annual Meeting Highlights Need for Neutral Collaborations to Advance Innovations in Biomedical Science and Healthcare
DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...
Who's afraid of the EU-Mercosur Agreement?
Vilified by some, defended by others and misunderstood by many, the “Mercosur Agreement” is a passionate subject these days ...